×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DXCM – dexcom, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DXCM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/1
01:43 am
dxcm
DexCom's Q4 Beat And 2026 Targets Tested By Rising CGM Competition [Yahoo! Finance]
Low
Report
DexCom's Q4 Beat And 2026 Targets Tested By Rising CGM Competition [Yahoo! Finance]
1/31
09:48 pm
dxcm
Q4 Preliminary Figures and 2026 Guidance Make DexCom (DXCM) Look Attractive [Yahoo! Finance]
Low
Report
Q4 Preliminary Figures and 2026 Guidance Make DexCom (DXCM) Look Attractive [Yahoo! Finance]
1/31
09:32 pm
dxcm
What DexCom (DXCM)'s Strong Q4 Beat and 2026 Margin Guidance Means For Shareholders [Yahoo! Finance]
Low
Report
What DexCom (DXCM)'s Strong Q4 Beat and 2026 Margin Guidance Means For Shareholders [Yahoo! Finance]
1/29
05:00 pm
dxcm
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Low
Report
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
1/27
08:57 am
dxcm
Barclays Downgrades Dexcom (DXCM) to Underweight Citing Intensifying Competition in Core Segments [Yahoo! Finance]
Low
Report
Barclays Downgrades Dexcom (DXCM) to Underweight Citing Intensifying Competition in Core Segments [Yahoo! Finance]
1/27
08:30 am
dxcm
Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.
Low
Report
Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.
1/27
08:00 am
dxcm
INVESTOR NOTICE: Kaskela Law Firm Announces Stockholder Investigation of DexCom, Inc. (NASDAQ: DXCM) and Encourages Long-Term Investors to Contact the Firm
Low
Report
INVESTOR NOTICE: Kaskela Law Firm Announces Stockholder Investigation of DexCom, Inc. (NASDAQ: DXCM) and Encourages Long-Term Investors to Contact the Firm
1/22
12:10 am
dxcm
1 Growth Stock Down 19% to Buy Right Now [Yahoo! Finance]
Low
Report
1 Growth Stock Down 19% to Buy Right Now [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/2
04:47 pm
dxcm
Form 4 DEXCOM INC For: Jan 29 Filed by: Leach Jacob Steven
Low
Report
Form 4 DEXCOM INC For: Jan 29 Filed by: Leach Jacob Steven
2/2
04:47 pm
dxcm
Form 4 DEXCOM INC For: Jan 29 Filed by: Stern Sadie
Low
Report
Form 4 DEXCOM INC For: Jan 29 Filed by: Stern Sadie
2/2
04:46 pm
dxcm
Form 4 DEXCOM INC For: Jan 29 Filed by: Sylvain Jereme M
Low
Report
Form 4 DEXCOM INC For: Jan 29 Filed by: Sylvain Jereme M
2/2
04:46 pm
dxcm
Form 4 DEXCOM INC For: Jan 29 Filed by: SAYER KEVIN R
Low
Report
Form 4 DEXCOM INC For: Jan 29 Filed by: SAYER KEVIN R
2/2
04:46 pm
dxcm
Form 4 DEXCOM INC For: Jan 29 Filed by: Brown Michael Jon
Low
Report
Form 4 DEXCOM INC For: Jan 29 Filed by: Brown Michael Jon
1/12
07:31 am
dxcm
Form 8-K DEXCOM INC For: Jan 07
Medium
Report
Form 8-K DEXCOM INC For: Jan 07
12/22
04:35 pm
dxcm
Form 8-K DEXCOM INC For: Dec 19
Low
Report
Form 8-K DEXCOM INC For: Dec 19
11/17
05:52 pm
dxcm
Form 4 DEXCOM INC For: Nov 14 Filed by: Collins Richard Alexander
Medium
Report
Form 4 DEXCOM INC For: Nov 14 Filed by: Collins Richard Alexander
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/6
Q3/2019 9/30/2019 EPS 0.650 ZacksConsensus 0.200 ActVsEst 0.450 - Beat
27.2%
2/13 Q4/2019 12/31/2019 EPS 1.150 ZacksConsensus 0.750 ActVsEst 0.400 - Beat 12.0%
4/28 Q1/2020 3/31/2020 EPS 0.440 ZacksConsensus 0.100 ActVsEst 0.340 - Beat 10.3%
4/8 Form 4 DEXCOM INC For: Apr 07 Filed by: SAYER KEVIN R 7.9%
4/15 Top-Ranked Medical Duo Breaks Out — But Only One Holds Onto Its Gain [Investor's Business Daily] 4.9%
4/1 Form 4 DEXCOM INC For: Mar 30 Filed by: Selvaraj Shelly Ramasamy 4.9%
6/11 Form 4 DEXCOM INC For: Jun 10 Filed by: SAYER KEVIN R 4.9%
3/9 Form 4 DEXCOM INC For: Mar 05 Filed by: Pacelli Steven Robert 4.8%
2/14 IBD 50 Watchlist Of Growth Stocks Adds Nvidia, Tradeweb, Veeva, Wex [Investor's Business Daily] 4.6%
3/25 Form 4 DEXCOM INC For: Mar 13 Filed by: DOUBLEDAY RICHARD 4.5%
2/13 Q4/2019 12/31/2019 EPS 1.150 ZacksConsensus 0.750 ActVsEst 0.400 - Beat 12.0%
4/28 Q1/2020 3/31/2020 EPS 0.440 ZacksConsensus 0.100 ActVsEst 0.340 - Beat 10.3%
4/8 Form 4 DEXCOM INC For: Apr 07 Filed by: SAYER KEVIN R 7.9%
4/15 Top-Ranked Medical Duo Breaks Out — But Only One Holds Onto Its Gain [Investor's Business Daily] 4.9%
4/1 Form 4 DEXCOM INC For: Mar 30 Filed by: Selvaraj Shelly Ramasamy 4.9%
6/11 Form 4 DEXCOM INC For: Jun 10 Filed by: SAYER KEVIN R 4.9%
3/9 Form 4 DEXCOM INC For: Mar 05 Filed by: Pacelli Steven Robert 4.8%
2/14 IBD 50 Watchlist Of Growth Stocks Adds Nvidia, Tradeweb, Veeva, Wex [Investor's Business Daily] 4.6%
3/25 Form 4 DEXCOM INC For: Mar 13 Filed by: DOUBLEDAY RICHARD 4.5%
TOP News Decliners
3/14
Coronavirus Bear Market: All Stocks Are Under Quarantine, But Keep Vertex, Biogen, Dexcom, Eli Lilly, Masimo Under Observation [Investor's Business Daily]
-15.6%
3/10 Form 8-K DEXCOM INC For: Mar 10 -9.6%
9/7 DexCom, Inc. (NASDAQ: DXCM) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -9.4%
8/1 DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Robert W. Baird from $180.00 to $186.00. They now have an "outperform" rating on the stock. -7.5%
4/27 DexCom Q1 2020 Earnings Preview [Seeking Alpha] -7.0%
10/8 Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM -5.9%
3/19 Hedge Funds Have Never Been This Bullish On DexCom, Inc. (DXCM) [Yahoo! Finance News] -5.4%
7/2 Dexcom Schedules Second Quarter 2019 Earnings Release and Conference Call for July 31, 2019 at 4:30 p.m. Eastern Time -4.6%
9/5 Form 4 DEXCOM INC For: Sep 03 Filed by: Balo Andrew K -4.4%
2/20 Form 4 DEXCOM INC For: Feb 18 Filed by: Collins Richard Alexander -4.1%
3/10 Form 8-K DEXCOM INC For: Mar 10 -9.6%
9/7 DexCom, Inc. (NASDAQ: DXCM) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -9.4%
8/1 DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Robert W. Baird from $180.00 to $186.00. They now have an "outperform" rating on the stock. -7.5%
4/27 DexCom Q1 2020 Earnings Preview [Seeking Alpha] -7.0%
10/8 Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM -5.9%
3/19 Hedge Funds Have Never Been This Bullish On DexCom, Inc. (DXCM) [Yahoo! Finance News] -5.4%
7/2 Dexcom Schedules Second Quarter 2019 Earnings Release and Conference Call for July 31, 2019 at 4:30 p.m. Eastern Time -4.6%
9/5 Form 4 DEXCOM INC For: Sep 03 Filed by: Balo Andrew K -4.4%
2/20 Form 4 DEXCOM INC For: Feb 18 Filed by: Collins Richard Alexander -4.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: